Research and Markets: Hepatitis C - Pipeline Review, Q1 2011

[Guest guest]

Research and Markets: Hepatitis C - Pipeline Review, Q1 2011

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/324388/hepatitis_c_pipe) has announced the addition of Global Markets Direct's new report "Hepatitis C - Pipeline Review, Q1 2011" to their offering.

“Hepatitis C - Pipeline Review, Q1 2011â€

'Hepatitis C - Pipeline Review, Q1 2011', provides an overview of the Hepatitis C therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis C, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hepatitis C. 'Hepatitis C - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

A snapshot of the global therapeutic scenario for Hepatitis C.

A review of the Hepatitis C products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Coverage of products based on various stages of development ranging from discovery till registration stages.

A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Coverage of the Hepatitis C pipeline on the basis of therapeutic class, route of administration and molecule type.

Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

Key discontinued pipeline projects.

Latest news and deals relating to the products.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Hepatitis C Overview

Therapeutics Development

An Overview of Pipeline Products for Hepatitis C

Hepatitis C Therapeutics under Development by Companies

Hepatitis C Therapeutics under Investigation by Universities/Institutes

Late Stage Products

Comparative Analysis

Mid Clinical Stage Products

Comparative Analysis

Early Clinical Stage Products

Comparative Analysis

Discovery and Pre-Clinical Stage Products

Comparative Analysis

Companies Involved in Hepatitis C Therapeutics Development

and much more...

For more information visit http://www.researchandmarkets.com/research/324388/hepatitis_c_pipe

Contacts

Research and Markets Wood, Senior Managerpress@...U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

http://www.businesswire.com/news/home/20110414006187/en/Research-Markets-Hepatitis---Pipeline-Review-Q1